No definition available.
Human immunodeficiency virus [HIV] disease resulting in other conditions
AB1_OTHER_CONDITIONS
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
687 |
4. Check minimum number of eventsNone |
687 |
5. Include endpointsNone |
687 |
6. Filter based on genotype QC (FinnGen only) |
541 |
Control definitions (FinnGen only)
- Control exclude
- AB1_HIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Human immunodeficiency virus [HIV] disease resulting in other conditions
based on the number of shared cases.
Similar with more cases:
- Human immunodeficiency virus [HIV] disease
- Human immunodeficiency virus [HIV] disease, including avohilmo
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2761 | 677 | 1897 |
| Only index persons | 2352 | 643 | 1709 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.02 | 0.05 |
| Only index persons | 0.05 | 0.02 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 37.99 | 33.57 | 39.95 |
| Only index persons | 38.02 | 33.45 | 39.74 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 541 | 100 | 441 |
| Unadjusted period prevalence (%) | 0.17 | 0.04 | 0.20 |
| Median age at first event (years) | 40.32 | 38.47 | 40.74 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 657
- Matched controls
- 6570
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
+∞
307.7
350
*
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
307.7
638
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
33.6
307.7
390
274
WW200
NOMESCO Finland
Immunization
399.5
307.7
527
66
Z25.1
ICD-10 Finland
Need for immunization against influenza
23.2
262.1
212
132
Z3231
NOMESCO Finland
Registered nurse
14.2
254.0
477
1036
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
239.7
215
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
208.8
189
*
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
13.0
201.5
236
271
Z2221
NOMESCO Finland
Medical doctor
7.3
145.6
378
1031
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
330.4
86.9
86
*
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
82.0
77
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
7.6
75.9
119
185
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
14.4
74.5
70
54
A51.0
ICD-10 Finland
Primary genital syphilis
393.2
72.1
71
*
Y25
ICPC
Fear sexually transm disease male
8.2
64.8
93
130
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
58.2
55
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
11.3
56.1
61
59
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
199.7
53.8
55
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
7.1
52.9
85
134
A54.5
ICD-10 Finland
Gonococcal pharyngitis
187.9
50.7
52
*
A51.9
ICD-10 Finland
Early syphilis, unspecified
491.1
46.9
46
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
46.2
393
2088
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.7
46.1
123
309
EB1AA, ,
SPAT
5.1
44.7
104
233
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
4.5
43.2
121
315
A53.9
ICD-10 Finland
Syphilis, unspecified
433.6
41.6
41
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
10.7
41.1
46
46
ZX114
NOMESCO Finland
Intramuscular
14.5
40.2
37
27
WX110, ,
SPAT
5.1
39.6
92
205
C10AA07
ATC
rosuvastatin; oral
2.8
37.4
307
1549
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
100.7
35.1
38
*
K02.9
ICD-10 Finland
Dental caries, unspecified
9.0
34.7
44
52
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
31.4
94
255
F43.29
ICD-10 Finland
Adaptation disorder UNS
6.8
30.8
50
79
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.9
29.6
56
103
ULA02
NOMESCO Finland
Kolposcopy
4.7
29.6
73
170
Z3226
NOMESCO Finland
Physiotherapist
3.0
29.1
153
595
WYA30, ,
SPAT
27.5
28.7
39
15
R4110
NOMESCO Finland
Physiotherapy
2.6
27.7
227
1110
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
4.6
26.8
68
162
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
5.0
26.5
60
130
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
26.2
25
*
TAB00
NOMESCO Finland
Lumbar puncture
4.7
26.1
63
144
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
7.3
25.3
38
55
XF400
NOMESCO Finland
ECG with 12 standard connections
3.0
24.9
130
501
N05CD07
ATC
temazepam; oral
3.7
24.4
86
260
ZXE00
NOMESCO Finland
One hour or less
2.3
24.3
278
1565
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.5
23.7
203
1003
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
7.8
23.5
33
44
Z2446
NOMESCO Finland
Social worker
3.8
22.5
73
208
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
+∞
22.0
21
*
Z71.8
ICD-10 Finland
Other specified counselling
2.3
21.6
261
1485
K02.2
ICD-10 Finland
Caries of cementum
4.5
21.4
55
132
Z20.6
ICD-10 Finland
Contact with and exposure to human immunodeficiency virus [HIV]
35.1
21.3
27
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
21.1
117
463
B90
ICPC
HIV-infection/AIDS
+∞
20.9
20
*
D11
ICPC
Diarrhoea
2.9
20.8
113
442
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
20.6
248
1404
A01AB04
ATC
amphotericin B; local oral
6.0
20.4
37
65
J05AB11
ATC
valaciclovir; oral
2.8
20.4
122
502
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
59.5
20.0
23
*
Z3232
NOMESCO Finland
Midwife
3.9
19.8
62
172
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.3
19.7
217
1181
O98.5
ICD-10 Finland
Other viral diseases complicating pregnancy, childbirth and the puerperium
205.9
19.7
20
*
J05AB01
ATC
aciclovir; systemic
2.4
18.9
160
777
WX290, ,
SPAT
4.3
18.3
48
117
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
18.1
161
797
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
+∞
17.8
17
*
S02.51
ICD-10 Finland
Fracture of tooth, open
2.8
17.7
96
374
Z01.2
ICD-10 Finland
Dental examination
2.0
17.5
344
2307
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.2
17.4
47
117
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
43.3
17.4
21
5
R50.9
ICD-10 Finland
Fever, unspecified
2.5
17.3
128
582
UJF30
NOMESCO Finland
Ileoscopy through colon
2.9
17.0
89
340
N05CF01
ATC
zopiclone; oral
2.1
16.8
213
1214
B20.9
ICD-10 Finland
HIV disease resulting in unspecified infectious or parasitic disease
+∞
16.7
16
*
Y71
ICPC
Gonorrhoea male
+∞
16.7
16
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.5
16.4
121
549
SPAT1263
SPAT
Sampling
0.4
16.3
70
1668
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.4
16.2
41
97
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
16.1
231
1373
P19
ICPC
Drug abuse
7.1
15.8
24
35
A97
ICPC
No disease
2.3
15.5
143
714
ZXD35
NOMESCO Finland
Usual procedure
4.5
15.4
38
88
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.4
14.8
55
171
A56.4
ICD-10 Finland
Chlamydial infection of pharynx
153.3
14.5
15
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
14.4
112
518
TQW99
NOMESCO Finland
Other minor procedure on skin
4.2
14.3
39
98
EB1SA, ,
SPAT
3.3
14.2
57
186
B02.9
ICD-10 Finland
Zoster without complication
3.3
13.9
53
168
UJH02
NOMESCO Finland
Anoscopy
3.9
13.4
40
107
R74
ICPC
Upper respiratory infection acute
1.9
13.2
257
1672
J01MA12
ATC
levofloxacin; systemic
2.2
13.2
127
643
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
12.8
176
1018
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
15.8
12.7
20
13
B20.1
ICD-10 Finland
HIV disease resulting in other bacterial infections
+∞
12.5
12
*
B23
ICD-10 Finland
Human immunodeficiency virus [HIV] disease resulting in other conditions
+∞
12.5
12
*
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
132.4
12.5
13
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.4
12.3
45
139
J01MA02
ATC
ciprofloxacin; systemic
1.8
12.0
246
1617
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
12.0
153
860
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
47.6
11.9
14
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
5.1
11.8
25
51
TLC02
NOMESCO Finland
Simple extraction of IUD
4.9
11.7
26
55
SPAT1153
SPAT
Removal of sutures
0.3
11.7
41
1108
-1, ,
NOMESCO Finland
1.8
11.6
236
1544
5AB01, ,
NOMESCO Finland
+∞
11.5
11
*
B20.0
ICD-10 Finland
HIV disease resulting in mycobacterial infection
+∞
11.5
11
*
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
11.5
11
*
A54.9
ICD-10 Finland
Gonococcal infection, unspecified
+∞
11.5
11
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.6
11.5
67
270
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
11.4
121
634
N06AB04
ATC
citalopram; systemic
2.0
11.3
135
739
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
4.9
11.3
25
53
KMAK, ,
NOMESCO Finland
1.8
11.2
372
2796
K05.31
ICD-10 Finland
Periodontitis pronounced
2.3
11.2
92
435
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.4
10.8
80
1564
ZXA05
NOMESCO Finland
Left side
2.0
10.7
141
799
SPAT1301
SPAT
No procedures
0.3
10.6
37
1006
T74.1
ICD-10 Finland
Physical abuse
4.1
10.6
29
73
EBA00, ,
SPAT
4.1
10.6
29
73
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
2.3
10.5
88
418
A52.9
ICD-10 Finland
Late syphilis, unspecified
+∞
10.4
10
*
B23.2
ICD-10 Finland
HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified
+∞
10.4
10
*
N05BA04
ATC
oxazepam; oral
1.9
10.4
162
970
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.3
10.2
36
976
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
8.1
10.2
22
28
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.6
10.2
60
243
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.3
10.0
37
115
SPAT1310
SPAT
Counselling related to known health issue
0.4
10.0
47
1112
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
8.3
9.9
21
26
JN4BD
NOMESCO Finland
Extensive body CT
2.5
9.9
67
290
B17.1
ICD-10 Finland
Acute hepatitis C
26.5
9.8
13
5
M01AC06
ATC
meloxicam; systemic, rectal
0.5
9.7
79
1501
ZXA00
NOMESCO Finland
Right side
1.9
9.5
148
883
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
9.4
90
451
A52.3
ICD-10 Finland
Neurosyphilis, unspecified
+∞
9.4
9
*
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.2
9.4
37
120
LDA10
NOMESCO Finland
Curettage of cervix uteri
4.4
9.2
23
54
C10AA01
ATC
simvastatin; oral
0.4
9.2
60
1244
SPAT1097
SPAT
Recording of ECG
0.2
9.0
7
393
WNF00
NOMESCO Finland
Infection source and contact determination
24.4
8.9
12
5
SPAT1249
SPAT
Treatment-related counselling outside office
0.5
8.9
78
1454
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
12.8
8.9
15
12
EBA05, ,
SPAT
4.6
8.9
21
47
B07.9
ICD-10 Finland
Verruca simplex
3.1
8.9
37
124
N87.1
ICD-10 Finland
Moderate cervical dysplasia
8.8
8.8
18
21
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.0
8.8
40
141
OAB43, ,
SPAT
0.6
8.8
154
2313
N05BA01
ATC
diazepam; systemic, rectal
2.1
8.7
88
450
M01AH05
ATC
etoricoxib; oral
0.6
8.7
280
3608
OAA67, ,
SPAT
0.4
8.6
56
1167
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.4
8.5
54
1138
D07AB08
ATC
desonide; topical
2.2
8.5
77
378
Y70
ICPC
Syphilis male
91.2
8.4
9
*
3044A
ICD-9 Finland
Drug dependence, Amphetamine and other psychostimulant dependence
91.2
8.4
9
*
A52.2
ICD-10 Finland
Asymptomatic neurosyphilis
+∞
8.3
8
*
A51.4
ICD-10 Finland
Other secondary syphilis
+∞
8.3
8
*
B21.3
ICD-10 Finland
HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
8.3
8
*
0788C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[AIDS, IMMUUNIKATO]
+∞
8.3
8
*
O98.3
ICD-10 Finland
Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium
+∞
8.3
8
*
0788B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[HIV-INFEKTIO,OIREISET TAUDINKUVAT]
+∞
8.3
8
*
B20.3
ICD-10 Finland
HIV disease resulting in other viral infections
+∞
8.3
8
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.2
8.3
69
327
N07BA03
ATC
varenicline; oral
2.5
8.3
55
236
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
8.3
188
1249
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
7.7
8.2
18
24
A23
ICPC
Risk factor NOS
2.1
8.1
79
399
SPAT1312
SPAT
General health counselling
0.4
8.1
54
1117
D19
ICPC
Teeth/gum symptom/complaint
1.7
8.0
214
1480
Z30.2
ICD-10 Finland
Sterilization
0.2
8.0
9
404
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.5
8.0
27
79
Z71.9
ICD-10 Finland
Counselling, unspecified
2.3
7.9
60
273
B37.4
ICD-10 Finland
Candidiasis of other urogenital sites
13.2
7.9
13
10
SPAT1324
SPAT
Screening procedure
0.2
7.9
7
363
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
7.9
58
261
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
7.8
44
174
ZXD20
NOMESCO Finland
Day surgery
2.1
7.7
81
420
EB1HA, ,
SPAT
3.8
7.7
23
62
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.7
7.6
151
962
Z2445
NOMESCO Finland
Psychologist
2.8
7.6
38
141
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
3.7
7.6
24
67
S29
ICPC
Skin symptom/complaint other
1.8
7.6
115
676
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.4
7.5
37
868
D06BB04
ATC
podophyllotoxin; topical
2.3
7.5
57
260
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.8
7.4
121
728
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.2
7.4
64
309
WZC30, ,
SPAT
0.1
7.3
*
282
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
11.0
7.3
13
12
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
11.0
7.3
13
12
D06BB10
ATC
imiquimod; topical
2.8
7.3
36
133
B20.4
ICD-10 Finland
HIV disease resulting in candidiasis
+∞
7.3
7
*
B21.0
ICD-10 Finland
HIV disease resulting in Kaposi sarcoma
+∞
7.3
7
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
7.3
52
231
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
7.1
52
233
RD210, ,
NOMESCO Finland
6.1
7.1
18
30
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
7.1
125
769
OAA80, ,
SPAT
0.4
7.1
39
875
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.6
7.1
41
165
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
3.9
7.0
20
52
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
5.9
7.0
18
31
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.6
6.9
15
20
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
11.1
6.8
12
11
EB4VA, ,
NOMESCO Finland
0.4
6.8
37
834
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.4
6.7
42
896
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
6.7
475
4069
R83
ICPC
Respiratory infection other
1.6
6.7
195
1369
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
6.6
68
350
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.5
6.6
42
177
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
6.3
6.5
16
26
G47.3
ICD-10 Finland
Sleep apnoea
0.5
6.5
81
1365
D82
ICPC
Teeth/gum disease
0.6
6.5
127
1890
T40.1
ICD-10 Finland
Poisoning: Heroin
70.5
6.4
7
*
D01AE16
ATC
amorolfine; topical
2.0
6.4
66
340
XX3DW
NOMESCO Finland
Time consuming IT work
0.2
6.4
8
336
EBA30
NOMESCO Finland
Extraction of root of tooth
2.3
6.4
46
205
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.6
6.4
35
137
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
6.3
44
193
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.4
6.3
42
181
N05AC01
ATC
periciazine; systemic
18.2
6.3
9
5
B20.2
ICD-10 Finland
HIV disease resulting in cytomegaloviral disease
+∞
6.3
6
*
B16.9
ICD-10 Finland
Acute hepatitis B without delta-agent and without hepatic coma
+∞
6.3
6
*
A53.0
ICD-10 Finland
Latent syphilis, unspecified as early or late
+∞
6.3
6
*
B20.7
ICD-10 Finland
HIV disease resulting in multiple infections
+∞
6.3
6
*
B22.0
ICD-10 Finland
HIV disease resulting in encephalopathy
+∞
6.3
6
*
B21.9
ICD-10 Finland
HIV disease resulting in unspecified malignant neoplasm
+∞
6.3
6
*
Z22.9
ICD-10 Finland
Carrier of infectious disease, unspecified
+∞
6.3
6
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.6
6.2
36
145
N05CF02
ATC
zolpidem; oral
1.8
6.2
110
677
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
5.4
6.2
17
32
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.4
6.2
22
67
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
0.2
6.2
11
438
TKC20
NOMESCO Finland
Catheterisation of bladder
2.5
6.1
38
158
R06AE07
ATC
cetirizine; oral
1.5
6.1
253
1916
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.3
6.1
12
450
N05BB01
ATC
hydroxyzine; systemic
2.5
6.1
37
153
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
6.0
78
1303
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
602
159
441.33
307.65
9.2
3.9
130.45
362.91
mg/l
2.00
594
78
628
22
6445.37
307.65
19.4
1.2
3004.60
—
u/ml
—
389
0
569
29
1458.40
307.65
3.3
2.6
31.72
39.05
%
1.93
112
21
599
47
1433.34
307.65
3.2
1.9
32.58
37.41
%
1.13
599
47
503
537
36.69
307.65
2.6
3.2
27.83
130.20
u/l
0.62
497
470
602
1861
27.70
232.34
6.9
3.8
30.09
77.08
e6/l
1.02
279
1317
119
13
111.56
231.58
3.6
1.6
—
—
—
0
0
627
2119
43.90
220.78
18.1
3.7
29.31
35.43
u/l
5.74
627
2018
135
68
24.73
180.90
1.1
1.1
—
—
—
0
0
628
2508
35.07
175.08
22.7
11.1
0.00
0.00
e9/l
0.64
611
2060
638
2689
48.46
165.82
22.3
7.0
50.14
56.94
%
57.74
638
2612
219
291
10.79
165.79
6.8
1.9
—
—
—
0
0
638
2735
47.08
161.44
22.4
7.2
36.36
28.08
%
82.37
638
2638
645
2899
68.06
152.66
22.3
7.0
0.54
0.59
e9/l
10.85
638
2542
227
350
9.38
151.43
6.8
1.9
—
—
—
0
0
645
2961
65.51
147.36
22.3
7.1
2.18
1.94
e9/l
8.78
638
2656
178
212
11.14
145.20
1.2
1.3
171.81
231.60
miu/ml
0.85
54
96
645
2992
64.28
144.77
22.5
7.4
0.18
0.20
e9/l
4.48
637
2665
611
2810
17.77
132.31
5.9
3.2
0.00
0.00
estimate
0.50
51
567
612
2840
17.86
130.61
5.9
3.2
0.00
0.01
estimate
0.79
49
508
646
3183
62.49
130.58
23.3
10.7
3.07
4.13
e9/l
51.24
638
2795
611
2836
17.49
130.15
5.9
3.2
21.33
8.89
estimate
0.24
54
567
548
2502
8.17
110.29
2.4
1.9
1.43
1.54
mmol/l
1.88
539
2196
649
4168
46.74
106.61
14.3
8.8
75.72
78.23
u/l
1.17
649
4006
383
1409
5.12
95.43
3.4
3.1
0.23
0.38
e6/l
0.74
261
1005
67
39
19.02
82.73
4.9
2.1
—
—
—
0
0
267
818
4.81
81.68
2.8
2.9
1.92
1.28
e6/l
0.35
99
376
396
1635
4.58
81.39
3.4
3.2
34.80
77.52
e6/l
0.51
277
1236
102
124
9.55
80.03
2.3
3.4
1.70
2.52
index
0.53
27
78
257
778
4.78
79.53
5.1
1.9
—
—
—
0
0
270
850
4.69
79.44
5.6
2.0
—
—
—
0
0
273
887
4.55
76.66
2.8
2.8
1.11
1.02
e6/l
0.11
106
444
72
64
12.51
70.21
2.5
1.8
—
—
—
0
0
398
1887
3.81
61.88
4.2
3.7
9.50
9.11
mmol/l
0.69
389
1659
120
238
5.95
59.70
1.4
1.4
—
—
—
0
0
68
84
8.91
52.17
2.1
2.4
19.86
48.61
iu/ml
—
10
8
99
211
5.35
45.04
1.1
1.6
0.21
0.07
iu/ml
0.33
54
32
93
201
5.22
41.54
2.6
1.7
—
—
—
0
0
644
4884
17.10
41.40
33.4
17.2
13.28
13.43
%
2.50
644
4838
78
151
5.73
39.29
1.1
1.5
149.14
150.49
au/ml
0.03
22
47
649
5471
16.29
37.28
27.6
13.0
88.37
88.87
ml/min/173m2
0.31
641
5055
41
48
9.04
32.58
3.3
2.4
980.28
808.32
e6/l
0.36
29
40
83
201
4.58
32.12
1.5
1.8
1.22
1.47
g/l
1.73
73
186
36
37
10.24
31.47
6.5
3.3
45.15
23.62
mu/l
2.16
36
37
229
1085
2.70
30.23
2.9
2.7
3.58
4.51
e6/l
0.50
209
995
51
85
6.42
29.80
1.2
1.3
—
—
—
0
0
51
85
6.42
29.80
1.2
1.3
—
—
—
0
0
40
58
7.28
26.57
4.0
3.6
—
—
—
0
0
120
437
3.14
25.36
2.4
2.4
77.24
74.15
ml/min/173m2
0.46
61
181
533
4015
2.74
23.19
4.6
4.1
10.78
9.04
mm/h
2.31
527
3831
622
5138
4.95
22.62
34.4
17.0
336.49
335.23
g/l
2.89
622
5119
641
5424
8.46
22.51
10.4
5.6
35.48
38.88
mmol/mol
25.27
641
5221
224
1239
2.23
19.51
1.6
1.6
18.87
19.40
nmol/l
0.30
215
1101
32
55
6.06
18.06
1.1
1.0
—
—
—
0
0
25
13
19.93
16.98
1.3
1.3
—
—
—
0
0
635
5629
4.83
14.32
16.1
14.1
26.28
23.22
mg/l
1.27
504
4551
22
35
6.47
13.36
1.5
3.9
915.36
601.60
u/ml
0.68
22
35
70
277
2.71
12.43
1.7
1.7
—
—
—
0
0
650
6092
7.28
12.22
33.1
17.3
83.49
79.97
umol/l
4.54
650
6050
71
287
2.65
12.08
1.7
1.3
—
—
—
0
0
20
17
12.09
11.39
2.3
1.8
—
—
iu/ml
—
0
0
650
6112
6.96
11.35
26.8
11.4
32.66
32.00
u/l
0.42
650
6014
94
450
2.27
11.07
1.5
1.6
—
—
—
0
0
38
113
3.51
10.98
2.2
1.8
—
—
—
0
0
23
28
8.47
10.88
1.0
1.2
2.58
1.97
umol/l
2.12
23
22
122
2060
0.50
10.86
2.4
3.2
23.36
34.88
ng/l
0.82
55
1323
291
2066
1.73
10.54
1.9
1.9
94.82
97.01
pmol/l
0.45
168
1195
50
181
2.91
10.47
2.3
3.5
—
—
—
0
0
111
581
2.10
10.44
1.8
2.0
—
—
—
0
0
41
1027
0.36
9.84
1.5
2.1
3.56
3.83
ratio
0.43
31
822
112
602
2.04
9.78
1.8
1.9
—
—
—
0
0
178
1122
1.80
9.58
2.3
2.1
2.41
2.74
mg/l
0.99
158
997
383
4616
0.59
9.49
3.2
3.7
58.56
52.30
u/l
0.72
369
4455
44
161
2.86
9.05
1.3
1.1
—
—
—
0
0
44
162
2.84
8.95
1.3
1.1
—
—
—
0
0
21
48
4.49
8.67
3.9
2.7
335.47
236.60
e6/l
0.99
15
42
160
1020
1.75
8.13
3.1
3.8
100.84
676.63
ng/l
3.46
114
751
12
533
0.21
8.03
7.3
6.1
—
—
—
0
0
149
2203
0.58
7.71
5.1
3.0
0.00
0.01
estimate
0.78
48
483
11
6
18.61
7.62
4.5
1.5
—
—
—
0
0
30
755
0.37
7.11
1.4
1.8
2.90
3.57
mmol/l
3.98
21
545
70
356
2.08
7.05
1.4
1.6
—
—
—
0
0
76
408
1.98
6.60
1.7
1.8
0.33
0.32
mg/l
0.09
48
222
279
2158
1.51
6.08
7.6
8.2
1.20
1.20
mmol/l
0.27
273
2028
19
53
3.66
6.07
4.5
2.0
—
—
—
0
0
88
513
1.83
5.95
2.7
3.6
0.25
1.85
mmol/l
2.77
73
445
23
76
3.10
5.70
1.3
1.4
—
—
—
0
0
107
674
1.70
5.54
2.3
3.4
10.62
8.69
umol/l
0.40
98
616
24
83
2.96
5.51
1.1
1.2
—
—
—
0
0
112
1657
0.61
5.37
5.3
2.7
0.00
0.01
estimate
1.47
48
455
31
129
2.47
5.04
2.0
3.8
—
2602.09
—
0
11
17
51
3.40
4.91
1.3
1.6
—
—
—
0
0
160
1149
1.52
4.77
1.6
1.5
—
—
—
0
0
58
320
1.89
4.67
2.2
4.5
78.03
92.12
ng/l
1.00
58
292
99
1462
0.62
4.61
6.3
3.3
0.00
0.00
estimate
0.80
52
520
179
2329
0.68
4.51
2.7
3.4
23.77
21.52
%
0.52
61
837
650
6314
3.76
4.38
35.8
20.9
239.14
246.40
e9/l
2.50
650
6228
16
427
0.36
4.30
1.1
1.2
0.89
0.92
g/l
0.09
16
427
650
6320
3.67
4.24
35.8
20.8
4.58
4.72
e12/l
11.61
650
6228
650
6320
3.67
4.24
37.4
21.6
42.37
42.23
%
0.41
650
6273
650
6318
3.70
4.23
35.8
20.8
93.36
90.46
fl
40.80
650
6278
79
493
1.68
4.23
3.1
3.3
—
—
—
0
0
14
34
4.18
4.23
3.2
4.9
1.00
0.88
index
0.21
14
34
16
420
0.37
4.15
1.1
1.1
1.46
1.44
g/l
0.11
16
420
116
800
1.55
4.13
1.8
2.0
—
—
—
0
0
6
232
0.25
4.12
2.8
3.2
24.90
24.74
mmol/l
—
6
224
650
6322
3.64
4.08
36.0
21.0
142.98
142.55
g/l
0.31
650
6280
14
42
3.38
4.06
3.4
4.7
21.71
13.03
index
1.73
14
34
240
2928
0.72
4.05
3.4
3.9
1.80
1.65
ug/l
0.18
226
2724
9
272
0.32
3.91
1.9
1.8
—
—
—
0
0
291
2414
1.37
3.79
7.2
8.6
1.20
1.20
mmol/l
0.81
271
2125
7
9
7.85
3.56
1.1
3.9
—
—
—
0
0
13
36
3.66
3.51
1.1
1.0
12.16
6.09
iu/ml
—
5
13
38
202
1.94
3.47
1.6
1.7
72.46
10.54
u/ml
—
8
55
212
1702
1.36
3.30
3.6
4.3
12.47
9.90
mg/mmol
0.27
146
1150
13
43
3.06
3.26
1.5
3.4
1030.85
1267.33
mg
0.23
13
43
28
137
2.09
3.21
1.8
1.3
17.77
18.24
e6/l
0.01
22
95
12
35
3.47
3.12
1.0
1.1
659.83
188.58
iu/ml
1.53
12
35
24
112
2.19
3.10
2.3
1.6
—
—
—
0
0
11
30
3.71
3.09
1.0
1.2
—
—
—
0
0
8
16
5.05
3.06
1.1
1.2
—
—
—
0
0
17
379
0.43
3.06
2.2
3.3
4.76
5.17
kpa
2.88
17
369
28
141
2.03
2.99
1.8
1.3
1139.00
1038.51
e6/l
0.03
22
105
13
46
2.86
2.93
1.2
1.1
—
—
—
0
0
266
2253
1.30
2.76
2.3
2.5
73.53
72.41
nmol/l
0.21
259
2107
110
823
1.40
2.59
2.3
2.4
30.84
29.55
s
1.91
110
807
204
2435
0.76
2.58
2.7
2.8
—
—
estimate
—
0
0
163
1302
1.34
2.55
1.3
1.3
2.53
1.69
u/ml
0.29
15
406
453
4142
1.30
2.51
3.6
3.2
—
—
—
0
0
64
915
0.67
2.47
1.6
1.6
410.38
32838097.50
pmol/l
0.97
56
807
27
146
1.89
2.41
1.3
2.7
55.22
35.94
mg/l
1.41
27
113
6
12
5.03
2.40
1.0
2.0
—
—
—
0
0
11
254
0.42
2.21
2.7
3.4
44.60
53.09
%
0.59
11
249
28
160
1.78
2.13
1.0
1.2
338.22
239.61
u/ml
0.64
18
101
26
146
1.81
2.09
1.2
2.7
43.51
45.45
mg/l
0.05
26
114
10
37
2.73
2.07
1.2
1.3
0.69
0.56
ratio
—
5
19
12
51
2.38
1.96
1.2
1.2
—
—
—
0
0
12
51
2.38
1.96
1.2
1.2
—
—
—
0
0
27
158
1.74
1.92
1.1
1.3
600.63
515.08
mg/l
0.45
27
151
79
1038
0.73
1.90
1.4
1.3
25.92
24.24
iu/ml
0.05
20
307
12
52
2.33
1.88
1.2
1.2
—
—
—
0
0
12
52
2.33
1.88
1.2
1.2
—
—
—
0
0
7
22
3.20
1.88
1.6
2.3
—
—
—
0
0
7
22
3.20
1.88
1.6
2.3
—
—
—
0
0
17
312
0.53
1.83
2.1
3.3
0.40
1.64
mmol/l
—
9
230
14
66
2.15
1.83
1.7
1.3
—
—
—
0
0
19
101
1.91
1.82
1.4
1.6
—
—
—
0
0
9
35
2.59
1.80
1.0
1.1
—
—
—
0
0
19
102
1.89
1.78
1.4
1.5
0.75
0.98
ratio
2.91
11
61
19
102
1.89
1.78
1.4
1.5
1.04
1.28
ratio
0.65
11
61
19
102
1.89
1.78
1.4
1.5
1.18
1.11
ratio
0.13
11
61
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
147
1.73
1.76
2.4
3.6
0.50
0.32
iu/ml
—
9
77
13
61
2.15
1.72
1.2
1.2
—
—
—
0
0
20
111
1.83
1.70
1.4
1.3
2.93
3.95
u/ml
0.48
15
55
12
55
2.20
1.68
1.2
1.2
—
—
—
0
0
27
425
0.62
1.66
1.7
2.1
8.65
9.98
ug/l
0.11
22
399
151
1261
1.26
1.65
1.9
1.9
2.25
1.12
mg/l
0.51
120
971
23
135
1.73
1.64
1.0
1.2
—
—
—
0
0
23
135
1.73
1.64
1.1
2.3
1.19
1.38
ratio
—
7
64
8
33
2.44
1.54
1.1
1.1
—
—
—
0
0
5
15
3.35
1.52
1.0
1.3
—
—
—
0
0
0
45
0.00
1.50
0.0
2.0
—
—
—
0
0
72
921
0.75
1.46
1.4
1.3
16.84
8.29
u/ml
0.26
16
377
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
135
1590
0.81
1.39
1.8
2.7
360.88
357.01
umol/l
0.18
121
1474
12
60
2.02
1.38
1.2
2.4
—
—
—
0
0
0
37
0.00
1.34
0.0
2.0
—
—
—
0
0
0
38
0.00
1.34
0.0
2.0
—
—
—
0
0
0
41
0.00
1.31
0.0
2.0
—
—
—
0
0
10
48
2.10
1.28
1.5
2.5
—
—
—
0
0
269
2435
1.18
1.26
2.8
3.0
142.80
152.03
ug/l
0.20
263
2341
22
139
1.60
1.24
1.8
2.5
174.31
130.63
ug/min
0.20
15
77
78
624
1.28
1.23
1.7
1.6
859.52
1163.50
nmol/l
2.91
69
497
5
19
2.64
1.22
1.2
1.1
—
—
—
0
0
40
290
1.40
1.20
1.3
2.2
43.80
39.42
u/l
0.61
35
269
18
109
1.67
1.20
2.8
4.2
4.73
5.03
kpa
1.84
18
109
19
117
1.64
1.19
1.4
1.3
1.45
4.70
u/ml
1.09
11
44
0
33
0.00
1.16
0.0
1.8
—
0.38
—
0
9
0
36
0.00
1.14
0.0
1.1
—
98.64
—
0
28
7
30
2.35
1.12
2.7
2.1
—
411.80
—
0
5
12
66
1.83
1.09
1.1
1.1
—
—
—
0
0
8
41
1.96
1.09
1.0
1.0
1789.50
1500.76
miu/ml
—
8
41
582
5654
1.26
1.08
17.8
16.3
3.91
3.98
mmol/l
9.70
572
5557
7
33
2.13
1.06
1.1
1.1
—
—
—
0
0
23
154
1.51
1.05
1.2
1.3
—
—
—
0
0
9
46
1.97
1.04
1.0
1.0
—
—
—
0
0
113
1315
0.83
1.03
2.5
3.3
888.58
958.09
ng/l
0.14
102
1085
161
1809
0.85
0.97
2.4
2.6
0.67
0.68
ug/l
0.03
111
901
98
830
1.21
0.97
3.1
3.0
2.44
2.43
mmol/l
0.79
83
754
6
27
2.23
0.93
4.2
1.7
—
—
—
0
0
65
531
1.25
0.90
2.0
2.0
48.02
36.82
nmol/l
2.16
65
520
13
79
1.66
0.88
1.1
1.4
—
—
—
0
0
109
944
1.19
0.86
2.6
4.2
0.82
0.82
mmol/l
0.02
101
906
8
45
1.79
0.84
1.1
1.2
—
—
—
0
0
8
45
1.79
0.84
1.1
1.2
—
—
—
0
0
6
32
1.88
0.82
1.3
3.2
—
63716.14
—
0
7
0
27
0.00
0.77
0.0
3.4
—
1.11
—
0
27
0
28
0.00
0.76
0.0
3.4
—
57.39
—
0
28
15
99
1.53
0.76
1.0
1.1
—
—
—
0
0
5
24
2.09
0.74
1.2
1.0
—
—
—
0
0
7
38
1.85
0.73
1.0
1.2
—
—
—
0
0
576
5632
1.18
0.72
16.9
16.1
139.20
139.72
mmol/l
6.66
569
5544
12
76
1.59
0.72
1.0
2.2
—
—
—
0
0
174
1584
1.13
0.72
5.3
3.6
2.36
2.35
mmol/l
0.87
159
1482
7
42
1.67
0.68
1.3
2.5
97.86
92.36
%
—
7
42
7
117
0.59
0.68
1.1
1.2
—
277.14
—
0
7
7
43
1.63
0.67
1.0
1.6
5.13
8.34
u/l
—
7
35
12
78
1.55
0.66
1.1
1.1
—
—
—
0
0
6
104
0.57
0.62
1.5
3.8
9.12
9.62
pmol/l
—
6
104
110
1227
0.88
0.61
5.1
3.2
1.02
1.02
kg/l
1.73
80
783
390
4057
0.90
0.61
2.9
3.6
13.72
14.57
pmol/l
11.94
373
3813
0
20
0.00
0.60
0.0
1.3
—
9.14
—
0
20
0
22
0.00
0.59
0.0
3.3
—
23.52
—
0
22
23
175
1.33
0.59
1.2
2.3
13.68
10.83
mg/l
2.45
23
169
0
23
0.00
0.58
0.0
1.9
—
113.96
—
0
23
17
123
1.39
0.58
1.6
1.5
12667.43
8869.55
e6/l
—
7
85
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
35
1.72
0.58
1.0
1.2
—
—
—
0
0
5
87
0.57
0.56
1.4
1.3
7.28
7.21
mmol/l
—
5
80
486
4990
0.90
0.55
4.3
4.4
1.83
1.82
mu/l
0.04
471
4717
25
195
1.29
0.55
1.5
1.2
—
—
—
0
0
9
62
1.46
0.53
1.0
1.2
—
—
—
0
0
71
622
1.16
0.53
16.0
12.5
-0.24
0.96
mmol/l
1.75
58
521
12
169
0.70
0.52
1.0
1.2
—
15.00
—
0
22
36
433
0.82
0.51
1.8
1.5
—
—
—
0
0
15
200
0.74
0.48
2.8
2.5
23.32
24.60
mmol/l
1.52
15
200
136
1252
1.11
0.48
2.5
2.4
—
—
—
0
0
8
118
0.67
0.46
1.0
1.9
—
—
—
0
0
0
15
0.00
0.41
0.0
8.5
—
11.13
—
0
15
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
2.0
—
—
—
0
0
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
8
113
0.70
0.37
1.4
1.3
—
—
—
0
0
10
135
0.74
0.36
1.0
1.2
—
0.97
—
0
7
12
157
0.76
0.36
1.1
1.1
—
6.95
—
0
21
32
273
1.18
0.35
1.2
1.4
17.50
19.52
iu/l
0.17
19
224
14
177
0.79
0.33
1.0
1.2
—
35.46
—
0
5
120
1126
1.08
0.30
2.3
2.1
1.62
1.47
%
1.51
108
1013
12
151
0.79
0.28
1.2
1.7
—
—
—
0
0
13
159
0.81
0.25
1.0
2.0
—
—
—
0
0
12
96
1.25
0.24
1.0
1.1
—
—
—
0
0
14
115
1.22
0.23
1.3
1.2
114.64
114.18
%
0.02
14
107
5
41
1.22
0.22
1.2
1.2
90.40
108.12
pmol/l
—
5
41
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
0.48
—
0
6
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
2.3
—
39.25
—
0
12
0
13
0.00
0.21
0.0
1.2
—
1.22
—
0
13
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
23
261
0.88
0.20
1.3
1.4
—
—
—
0
0
13
155
0.84
0.20
1.1
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
12
144
0.83
0.20
1.0
1.8
—
—
—
0
0
14
119
1.18
0.18
1.3
1.2
—
—
—
0
0
11
131
0.84
0.17
1.5
1.4
—
—
—
0
0
12
101
1.19
0.16
1.7
1.5
—
—
—
0
0
14
121
1.16
0.15
1.1
1.6
—
—
—
0
0
33
304
1.09
0.14
1.3
1.5
11.30
6.23
u/l
0.77
19
246
7
86
0.81
0.14
1.3
1.5
234.29
298.31
mu/l
—
7
70
30
276
1.09
0.14
1.5
1.7
269.14
259.55
mu/l
0.17
30
258
14
125
1.12
0.10
2.3
2.6
9.29
8.28
kpa
1.21
14
125
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
28
298
0.94
0.08
1.5
2.6
0.57
0.62
%
0.37
28
298
5
62
0.80
0.08
1.0
2.1
—
—
—
0
0
6
71
0.84
0.07
1.0
1.4
60.33
136.48
pmol/l
—
6
66
8
76
1.05
0.07
1.3
2.1
—
—
—
0
0
12
108
1.11
0.07
1.3
1.7
—
—
—
0
0
9
100
0.90
0.06
1.0
2.3
—
—
—
0
0
14
149
0.94
0.03
1.0
2.0
—
—
—
0
0
229
2305
0.99
0.03
10.2
11.3
1.18
1.17
inr
0.13
180
1911
11
117
0.94
0.01
1.2
1.5
217.09
169.47
pmol/l
0.94
11
117
12
114
1.05
0.00
1.1
1.1
—
1.92
—
0
9
14
134
1.05
0.00
1.0
1.2
—
46.13
—
0
12
30
296
1.01
0.00
1.1
1.1
—
—
—
0
0
34
337
1.01
0.00
1.1
1.2
125.83
128.49
u/ml
—
6
126
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
2.18
—
0
5
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
0.16
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
1.45
—
0
6
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
1.23
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.7
—
—
—
0
0
5
59
0.85
-0.00
2.2
2.7
2.56
6.98
umol/l
—
5
46
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.5
—
—
—
0
0
5
56
0.89
-0.00
1.0
2.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.6
—
0.38
—
0
8
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
14
140
1.00
-0.00
1.4
2.2
22.07
32.70
u/ml
0.53
14
134
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_OTHER_CONDITIONS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_CONDITIONS | 4.108 [2.91, 5.8] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.455 |
During the follow-up period (1.1.1998 — 31.12.2019), 54 out of 643 females with AB1_OTHER_CONDITIONS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_CONDITIONS | 2.837 [2.42, 3.32] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.018 |
During the follow-up period (1.1.1998 — 31.12.2019), 266 out of 1729 males with AB1_OTHER_CONDITIONS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_OTHER_CONDITIONS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.439% | 0.538% |
| 5 | 2.69% | 3.498% |
| 10 | 5.971% | 8.836% |
| 15 | 12.195% | 15.784% |
| 20 | 20.703% | 25.317% |
Relationships between endpoints
↥Index endpoint: AB1_OTHER_CONDITIONS – Human immunodeficiency virus [HIV] disease resulting in other conditions
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data